BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11864799)

  • 1. Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated.
    Grabenstein JD; Guess HA; Hartzema AG; Koch GG; Konrad TR
    J Clin Epidemiol; 2002 Mar; 55(3):279-84. PubMed ID: 11864799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vaccination by community pharmacists among adult prescription recipients.
    Grabenstein JD; Guess HA; Hartzema AG; Koch GG; Konrad TR
    Med Care; 2001 Apr; 39(4):340-8. PubMed ID: 11329521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. People vaccinated by pharmacists: descriptive epidemiology.
    Grabenstein JD; Guess HA; Hartzema AG
    J Am Pharm Assoc (Wash); 2001; 41(1):46-52. PubMed ID: 11216111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National survey of pharmacy-based immunization services.
    Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
    Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates.
    Wehbi NK; Wani RJ; Klepser DG; Murry J; Khan AS
    Vaccine; 2019 Jan; 37(1):56-60. PubMed ID: 30471954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "You need to be an advocate for yourself": Factors associated with decision-making regarding influenza and pneumococcal vaccine use among US older adults from within a large metropolitan health system.
    Kaljee LM; Kilgore P; Prentiss T; Lamerato L; Moreno D; Arshad S; Zervos M
    Hum Vaccin Immunother; 2017 Jan; 13(1):206-212. PubMed ID: 27625007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily versus single-day offering of influenza vaccine in community pharmacies.
    Grabenstein JD
    J Am Pharm Assoc (2003); 2009; 49(5):628-31. PubMed ID: 19748870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza and pneumococcal vaccination in the emergency department: is it feasible?
    Wrenn K; Zeldin M; Miller O
    J Gen Intern Med; 1994 Aug; 9(8):425-9. PubMed ID: 7965235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
    Loubet P; Kernéis S; Groh M; Loulergue P; Blanche P; Verger P; Launay O
    Vaccine; 2015 Jul; 33(31):3703-8. PubMed ID: 26073016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance.
    Opstelten W; Hak E; Verheij TJ; van Essen GA
    Am J Med; 2001 Oct; 111(6):474-9. PubMed ID: 11690574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Pneumococcal Vaccination Availability in Under-Vaccinated Rural Counties: A Pharmacy Perspective.
    Colorafi K; Panther S; McKeirnan K; Potyk D; McCarthy J; Temple S
    Consult Pharm; 2018 Mar; 33(3):163-170. PubMed ID: 29720302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
    Trmal J; Havlícková M; Bícová R; Bitterová Z; Kelerová J
    Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
    Taitel M; Cohen E; Duncan I; Pegus C
    Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
    McConeghy KW; Wing C
    Vaccine; 2016 Jun; 34(30):3463-8. PubMed ID: 27219340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
    Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
    [No Abstract]   [Full Text] [Related]  

  • 16. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators.
    Foy JE; Hendriksz T; Malouf P; Tobin A
    J Am Osteopath Assoc; 2013 Feb; 113(2):134-43. PubMed ID: 23412675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population characteristics associated with pharmacy-based influenza vaccination in United States survey data.
    Inguva S; Sautter JM; Chun GJ; Patterson BJ; McGhan WF
    J Am Pharm Assoc (2003); 2017; 57(6):654-660. PubMed ID: 28830660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines.
    Çiftci F; Şen E; Demir N; Çiftci O; Erol S; Kayacan O
    Hum Vaccin Immunother; 2018 Jan; 14(1):111-117. PubMed ID: 29049005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001).
    Nowalk MP; Zimmerman RK; Shen S; Jewell IK; Raymund M
    J Am Geriatr Soc; 2004 Jan; 52(1):25-30. PubMed ID: 14687311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient experiences with influenza immunizations administered by pharmacists.
    Isenor JE; Wagg AC; Bowles SK
    Hum Vaccin Immunother; 2018 Mar; 14(3):706-711. PubMed ID: 29303681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.